SCHEMBL866292

SCHEMBL866292

O=C(O)CC(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACLY P53396 3/20 0.41
THRB P10828 1/20 0.40
ALDH1A1 P00352 1/20 0.38
HMGCR P04035 1/20 0.38
CHRM1 P11229 1/20 0.38
TBXA2R P21731 1/20 0.38
ADRA1A P35348 1/20 0.38
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
TET2 Q6N021 1/20 0.32
CPT2 P23786 2/20 0.32
KDM4E B2RXH2 1/20 0.32
FFAR1 O14842 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3861185 0.92 THRB (0.44) ACLYTHRBALDH1A1HMGCRCHRM1
SCHEMBL3862118 0.90 THRB (0.48) ACLYTHRBALDH1A1HMGCRCHRM1
SCHEMBL8614474 0.90 THRB (0.48) ACLYTHRBALDH1A1HMGCRCHRM1
SCHEMBL8618188 0.90 THRB (0.48) ACLYTHRBALDH1A1HMGCRCHRM1
SCHEMBL3858790 0.90 THRB (0.48) ACLYTHRBALDH1A1HMGCRCHRM1
SCHEMBL3864225 0.90 THRB (0.48) ACLYTHRBALDH1A1HMGCRCHRM1
SCHEMBL3863734 0.90 THRB (0.48) ACLYTHRBALDH1A1HMGCRCHRM1
SCHEMBL8618888 0.90 THRB (0.48) ACLYTHRBALDH1A1HMGCRCHRM1
SCHEMBL11227427 0.88 ACLY (0.44) ACLYTHRBALDH1A1HMGCRCHRM1
Ammonia Solution, Strong SCHEMBL27987372 0.87 THRB (0.46) ACLYTHRBALDH1A1HMGCRCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595396-B2 Process for preparing polyisocyanates containing iminooxadiazinedione groups BAYER MATERIALSCIENCE AG (DE) 2009-09-29 US claimed
EP-1645577-B1 Process for preparing polyisocyanates having iminoooxadiazinedione groups BAYER MATERIALSCIENCE AG (DE) 2008-08-20 EP claimed
US-20060079694-A1 Process for preparing polyisocyanates containing iminooxadiazinedione groups BAYER MATERIALSCIENCE AG 2006-04-13 US claimed
EP-1645577-A1 Process for preparing polyisocyanates having iminoooxadiazinedione groups Bayer MaterialScience AG (DE) 2006-04-12 EP claimed
EP-4008757-B1 BLOCKED POLYISOCYANATE COMPOSITION, ONE-COMPONENT COATING COMPOSITION, COATING FILM AND COATED ARTICLE ASAHI CHEMICAL IND (JP) 2026-03-18 EP disclosed
US-12410277-B2 Block polyisocyanate composition, resin composition, resin film and layered body ASAHI KASEI KABUSHIKI KAISHA (JP) 2025-09-09 US disclosed
EP-3527593-B1 ISOCYANATE COMPOSITION, METHOD FOR PRODUCING ISOCYANATE COMPOSITION, AND METHOD FOR PRODUCING ISOCYANATE POLYMER ASAHI CHEMICAL IND (JP) 2025-07-23 EP disclosed
EP-3527600-B1 ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER ASAHI CHEMICAL IND (JP) 2025-07-09 EP disclosed
US-12173180-B2 Polyaspartic coating composition, coating film, and coated article ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-12-24 US disclosed
EP-3738682-B1 COATING METHOD AND COATING FILM ASAHI CHEMICAL IND (JP) 2024-09-25 EP disclosed
US-20240287243-A1 BLOCKED POLYISOCYANATE COMPOSITION, RESIN COMPOSITION, RESIN FILM AND LAMINATE ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-08-29 US disclosed
EP-4364944-A1 BLOCK POLYISOCYANATE COMPOSITION, RESIN COMPOSITION, RESIN FILM, AND LAYERED BODY Asahi Kasei Kabushiki Kaisha (JP) 2024-05-08 EP disclosed
EP-1645577-B1 Process for preparing polyisocyanates having iminoooxadiazinedione groups BAYER MATERIALSCIENCE AG (DE) 2008-08-20 EP disclosed
US-20080001515-A1 FLUORESCENT COMPLEX AND LIGHTING SYSTEM USING THE SAME KABUSHIKI KAISHA TOSHIBA (JP) 2008-01-03 US disclosed
EP-1860094-A1 Photocrosslinkable materials Rolic AG (CH) 2007-11-28 EP disclosed
WO-2007071091-A1 PHOTOCROSSLINKABLE MATERIALS ROLIC AG (CH) 2007-06-28 WO disclosed
US-20060079694-A1 Process for preparing polyisocyanates containing iminooxadiazinedione groups BAYER MATERIALSCIENCE AG 2006-04-13 US disclosed
EP-1645577-A1 Process for preparing polyisocyanates having iminoooxadiazinedione groups Bayer MaterialScience AG (DE) 2006-04-12 EP disclosed
US-6264929-B1 COMPLEX WELLA AKTIENGESELLSCHAFT (DE) 2001-07-24 US disclosed
EP-0837085-A1 POLYCARBONATE-BASE POLYMER, PRODUCTION PROCESS, RESIN COATING FLUID PREPARED THEREFROM, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR PREPARED THEREFROM IDEMITSU KOSAN COMPANY LIMITED (JP) 1998-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080001515-A1 FLUORESCENT COMPLEX AND LIGHTING SYSTEM USING THE SAME LAGE3, KCNK4, KCNK5 ACLY 3557/4885THRB 798/4885ALDH1A1 2366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.